Anakinra

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Anakinra and local guidelines before prescribing.

IL-1 antagonist

Mechanism

Interleukin-1 receptor antagonist.

Uses

Autoinflammatory disease, adult-onset Still disease, gout flares (refractory), pericarditis (recurrent).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Injection-site reactions, infections, neutropenia.

Interactions

Avoid with TNF inhibitors.

Contraindications and cautions

Active infection, neutropenia

Monitoring

FBC, infection

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose if CrCl below 30

Overdose and reversal

Supportive

Special advice

Daily injection; renal dose adjustment.

More from the textbook: uses, cautions and other points
Where it is discussed in the book